Pharmaceutical-Grade Methylene Blue Brands: How to Read a COA and Verify Purity
Learn what makes methylene blue pharmaceutical-grade, how to read a Certificate of Analysis, and what to look for when comparing brands.
Methylene Blue vs. NAD+ Precursors (NMN/NR): Two Distinct Approaches to Mitochondrial Support
Methylene blue and NAD+ precursors like NMN and NR target mitochondrial health through different mechanisms. Here’s an honest comparison of both approaches.
Methylene Blue: 140 Years of Pharmaceutical Use — From Malaria Dye to Nootropic
Methylene blue has been a medical tool since 1891. Learn its history, proposed mechanisms, FDA-approved uses, serious drug interactions, and current research.
Methylene Blue Neuroprotection: What Animal Models Reveal About Parkinson’s, Stroke, and TBI
Evidence-based review of methylene blue neuroprotection in Parkinson’s, ischemic stroke, and TBI animal models—mechanisms, key findings, and safety limits.
Methylene Blue Dosage: How Much to Take, When, and Safety Notes (2026)
Methylene blue (MB) has garnered significant attention within biohacking and longevity communities for its potential in mitochondrial optimization and cognitive
Methylene Blue Toxicity at High Doses: The Dose Paradox, Methemoglobinemia, and Neurotoxicity Risks
High-dose methylene blue can cause the very methemoglobinemia it treats at low doses. Learn the toxicity thresholds, mechanisms, and serious risks.
Methylene Blue and Cognitive Enhancement: What the Human Clinical Evidence Actually Shows
An honest review of methylene blue’s proposed cognitive mechanisms, its FDA-approved uses, the limits of current human evidence, and critical safety considerati
Methylene Blue Stacking: Safe Combinations, Dangerous Interactions, and What the Evidence Actually Shows
Methylene blue stacking: dangerous combinations, G6PD risks, dose limits, and what the evidence shows. Informational, not medical advice.
Methylene Blue and Alzheimer’s Disease: How a Century-Old Dye Targets Tau Protein Aggregation
Methylene blue is under clinical investigation as a tau aggregation inhibitor for Alzheimer’s disease. Here is what the evidence actually shows.
Pharmaceutical-Grade Methylene Blue Supplements: What to Look For and What to Avoid in 2025
A clear-eyed guide to buying pharmaceutical-grade methylene blue in 2025—covering purity, dosing, mechanisms, and critical safety warnings.